Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations

Anton Pottegard; Søren Friis; Til Stürmer; Jesper Hallas; Shahram Bahmanyar

doi:10.1111/bcpt.12946

Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations

Anton Pottegard, Søren Friis, Til Stürmer, Jesper Hallas, Shahram Bahmanyar

Section of Social Medicine

30 Citations (Scopus)

61 Downloads (Pure)

Original language	English
Journal	Basic & Clinical Pharmacology & Toxicology
Volume	122
Issue number	5
Pages (from-to)	451-459
Number of pages	9
ISSN	1742-7835
DOIs	https://doi.org/10.1111/bcpt.12946
Publication status	Published - May 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bcpt.12946Licence: CC BY

Considerations for Pharmacoepidemiological Studies of Drug–Cancer AssociationsFinal published version, 104 KBLicence: CC BY

Cite this

@article{444133964e5744a4959f66fca410d0ac,

title = "Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations",

author = "Anton Pottegard and S{\o}ren Friis and Til St{\"u}rmer and Jesper Hallas and Shahram Bahmanyar",

year = "2018",

month = may,

doi = "10.1111/bcpt.12946",

language = "English",

volume = "122",

pages = "451--459",

journal = "Basic and Clinical Pharmacology and Toxicology",

issn = "1742-7835",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations

AU - Pottegard, Anton

AU - Friis, Søren

AU - Stürmer, Til

AU - Hallas, Jesper

AU - Bahmanyar, Shahram

PY - 2018/5

Y1 - 2018/5

U2 - 10.1111/bcpt.12946

DO - 10.1111/bcpt.12946

M3 - Review

C2 - 29265740

SN - 1742-7835

VL - 122

SP - 451

EP - 459

JO - Basic and Clinical Pharmacology and Toxicology

JF - Basic and Clinical Pharmacology and Toxicology

IS - 5

ER -

Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations

UN SDGs

Access to Document

Fingerprint

Cite this